Molecular structural heterogeneity of bisphenols governs their serum albumin binding

Bisphenol A (BPA) and its analogs (bisphenol F, BPF: bisphenol AF, BPAF: bisphenol S, BPS; and tetrabromobisphenol A, TBBPA) are transported by blood and bind estrogen receptors of target organs or cells. They were confirmed to bind human serum albumin (HSA) in blood, and the binding constants of BPA (5.14 x 10(3) M-1), BPF (1.05 x 10(4) M-1). and BPS (7.89 x 10(3) M-1) determined via equilibrium dialysis shows moderate binding ability with multiple binding sites. The HSA-water partition coefficients (log K-HW > 3) are greater than their octanol-water distribution coefficients, and may follow the order: TBBPA > BPAF > BPA (3.75) > BPF (3.61) > BPS (3.27). Functional groups and substitutions of bisphenols (BPs) determine the fluorescence quenching of Trp214 in HSA. The effects follow: TBBPA (4.41 x 10(14) M-1 s(-1)) BPS (4.08 x 10(12) M-1 s(-1)) > BPAF (1.20 x 10(12) M-1 s(-1)) > BPF (3.06 x 10(11) M-1 s(-1)) approximate to BPA (4.47 x 10(11) M-1 s(-1)), which is in line with the molecular docking results. In this process, the enzymatic characteristics of HSA were changed simultaneously, as evidenced by decreased K-m and V-max except for BPS (increased K-m and V-ma(x)) and increased catalytic efficiency, which may improve the hydrolysis of other drugs. However, the native conformation of the protein underwent locally adaptive changes due to the reversible binding. Overall, these data provide a mechanistic explanation for the transport of BPs in human blood, which may affect their retention and toxicity. (C) 2021 Published by Elsevier B.V.

Automated summary

Bisphenol A and its analogs are transported by blood and bind estrogen receptors in target organs or cells, with moderate binding ability to human serum albumin. This interaction may influence their retention and toxicity in the bloodstream.